0001726645-18-000001.txt : 20180108 0001726645-18-000001.hdr.sgml : 20180108 20180108123117 ACCESSION NUMBER: 0001726645-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20180108 DATE AS OF CHANGE: 20180108 EFFECTIVENESS DATE: 20180108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Polymbios Capital Global Fund, Ltd. CENTRAL INDEX KEY: 0001726645 IRS NUMBER: 981401491 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-302622 FILM NUMBER: 18515606 BUSINESS ADDRESS: STREET 1: 300 PARK AVENUE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 347-470-0957 MAIL ADDRESS: STREET 1: 300 PARK AVENUE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 D 1 primary_doc.xml X0708 D LIVE 0001726645 Polymbios Capital Global Fund, Ltd. c/o Polymbios Investment Management LLC 300 PARK AVENUE, 12TH FLOOR NEW YORK NY NEW YORK 10022 347-470-0957 CAYMAN ISLANDS None None Other Cayman Islands Exempted Company true 2017 N/A Polymbios Investment Management LLC 300 PARK AVENUE 12TH FLOOR NEW YORK NY NEW YORK 10022 Executive Officer Investment Manager of the Issuer Mikael Olofsson 300 PARK AVENUE 12TH FLOOR NEW YORK NY NEW YORK 10022 Executive Officer Director Managing Member of Polymbios Investment Management LLC and Director of the Issuer Ingemar Svensson 300 PARK AVENUE 12TH FLOOR NEW YORK NY NEW YORK 10022 Executive Officer Director Managing Member of Polymbios Investment Management LLC and Director of the Issuer Cristina Dolan 300 PARK AVENUE 12TH FLOOR NEW YORK NY NEW YORK 10022 Executive Officer Director Managing Member of Polymbios Investment Management LLC and Director of the Issuer Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.1 false true true true false 0 Indefinite 0 Indefinite false 0 0 true 0 true 0 true Polymbios Investment Management LLC and certain persons listed in Item 3 may receive a management fee based on the value of the issuer's assets and/or a performance-based fee based on the issuer's profits. false Polymbios Capital Global Fund, Ltd. Mikael Olofsson Mikael Olofsson Director of Polymbios Capital Global Fund, Ltd. 2018-01-08